InsidersTradesSigma
Discover the full record of transactions filed by Paggiarino Dario A., Directeur Médical. Director active across 1 companies, notably EyePoint Pharmaceuticals, Inc.. Cumulatively, 5 reports have been logged. The latest transaction was filed on 28 February 2022 — Levée d'options. Regulator: SEC (Form 4). All data is openly available.
5 of 5 declarations
Paggiarino Dario A. is the Chief Medical Officer of EyePoint Pharmaceuticals, Inc. He is responsible for leading the company's medical and clinical initiatives. His role is essential for the development of new treatments and ensuring compliance with medical regulations. Dario brings significant expertise in the medical field, contributing to the mission of EyePoint Pharmaceuticals.